(Q36291594)

13 August 2017

1 reference

14 September 2020

Ongoing and unsaid on oxaliplatin: the hope (English)

1 reference

13 August 2017

organoplatinum compounds

1 reference

12 November 2019

1 reference

14 September 2020

1 reference

14 September 2020

1 reference

Cvitkovic E

1

1 reference

PMC publication ID

2149881

13 August 2017

language of work or name

English

0 references

publication date

1 June 1998

8 references

British Journal of Cancer

13 August 2017

13 March 2019

14 March 2019

24 March 2019

3 April 2019

12 November 2019

29 May 2020

14 September 2020

7 references

13 August 2017

13 March 2019

14 March 2019

24 March 2019

3 April 2019

12 November 2019

14 September 2020

77 Suppl 4

1 reference

13 August 2017

8-11

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.429

13 August 2017

0 references

cites work

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

Cellular accumulation of the anticancer agent cisplatin: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2149881

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9647613

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1998.429

1 reference

13 August 2017

1 reference

PMC publication ID

2149881

13 August 2017

PubMed publication ID

9647613

1 reference

PMC publication ID

2149881